Colithé
Colithé, licence 80021906: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Clef des Champs Inc.
- NPN or DIN-HM
- 80021906
- Status
- Inactive licence
- Licence date
- 26 October 2010
- Revision date
- Not provided
- Form
- Tisane
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Althaea officinalis Source : Racine | 43.0 mg | Not calculated |
| Avena sativa Source : Parties aériennes | 65.0 mg | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2.0 Année(s) ; maximum: 4.0 Année(s) | 2.0 once(s) | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
| Enfants | maximum: 2.0 Année(s) | 2.0 once(s) | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Utilisé traditionnellement en herboristerie occidentale pour soulager les coliques et les troubles digestifs chez les enfants et les nourrissons.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de la santé si les symptômes persistent ou s'aggravent. Éviter la prise simultanée de médicaments d'ordonnance.
- Contre-indications
Ne pas utiliser en cas d'allergie a l'anéthol, aux aplacées ou astéracées
- Effets indésirables connus
Une hypersensibilité peut se manifester. Si tel est le cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80021906
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.